Testicular Dysgenesis Syndrome and Leydig Cell Function
Article first published online: 22 JAN 2008
DOI: 10.1111/j.1742-7843.2007.00197.x
© 2008 The Authors
Additional Information
How to Cite
Joensen, U. N., Jørgensen, N., Meyts, E. R.-D. and Skakkebæk, N. E. (2008), Testicular Dysgenesis Syndrome and Leydig Cell Function. Basic & Clinical Pharmacology & Toxicology, 102: 155–161. doi: 10.1111/j.1742-7843.2007.00197.x
Publication History
- Issue published online: 22 JAN 2008
- Article first published online: 22 JAN 2008
- (Received July 3, 2007; Accepted October 20, 2007)
- Abstract
- Article
- References
- Cited By
Abstract: Fertility among human beings appear to be on the decline in many Western countries, and part of the explanation may be decreasing male fecundity. A hypothesis has been put forward that decreasing semen quality may be associated with a testicular dysgenesis syndrome (TDS), a spectrum of disorders originating in early foetal life. TDS comprises various aspects of impaired gonadal development and function, including testicular cancer. A growing body of evidence, including animal models and research in human beings, points to lifestyle factors and endocrine disrupters as risk factors for TDS. We present our view of the emerging role of Leydig cell dysfunction with subsequent decreased testosterone levels in the pathogenesis of TDS.

1742-7843/asset/olbannerleft.gif?v=1&s=12980b63713000301f48d193cfbc971caf1660ff)
